0
ARTICLE |

Artificial Tobacco Substitutes

Gio B. Gori, PhD
JAMA. 1975;234(5):489-490. doi:10.1001/jama.1975.03260180029017.
Text Size: A A A
Published online

THE SEARCH for man-made materials that could substitute, wholly or in part, for the tobacco in cigarettes has been going on for almost two decades, but only in the last few years have such products commanded serious attention.1-3

The reasons for this interest are twofold: these products, at least in their latest formulations, promise to reduce the toxic effects of smoke and offer the allure of potential economic advantage over the use of natural tobacco.

Economic Considerations  At present, however, the manufacturing of artificial tobacco substitutes (ATS) being offered commercially is sufficiently expensive to push their price range into the upper quartile of international tobacco prices (US patent 3,545,448; UK patents 1,113,979 and 1,244,441; Canadian patents 895,112 and 931,851). Consequently, a more evident advantage is that ATS can be supplied to suit a particular production schedule and, therefore, do not require the expensive storage procedures of tobacco. Furthermore, ATS

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs